Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and approve consider, approve and take ....
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Bio-Tech Ltd has informed BSE about a Board of Directors meeting scheduled for Wednesday, January 21, 2026. The main business on the agenda is to consider, approve, and take on record the Un-Audited Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2025. This is the standard Q3 FY26 results announcement meeting. The trading window for designated employees and their immediate relatives remains closed until 48 hours after the results are declared, as previously intimated on December 31, 2025. No other specific agenda items were disclosed beyond 'any other business with the permission of the Chair'.
This is a routine regulatory filing and does not impact the stock price. Investors should watch for the actual Q3 FY26 results announcement, which is expected on or shortly after January 21, 2026, for any meaningful business updates or financial performance signals.